Trung tâm Thông tin - Thư viện Trường Đại học Y Dược Hải Phòng

NLM	C20
Tác giả CN	Đào Thị Hải Ly
Nhan đề	CD63 as a potential biomarker for patients with ovarian cancer
Thông tin xuất bản	ELSEVIER,2025
Tóm tắt	In terms of stages, CD63 expression was significantly higher in patients with stage IV compared to those with stage I OC (p = 0.003). In terms of histological type, CD63 expression was significantly higher in high-grade serous carcinoma (HGSC) than in clear cell carcinoma (CCC) with OC (p = 0.009). Furthermore, CD63 levels were significantly higher in advanced-stage, HGSC than in patients with early-stage, non-HGSC and early-stage, HGSC OC (p = 0.045 and p = 0.002, respectively). In the Neoadjuvant chemotherapy (NAC) of 12 patients with OC assessed as having either a partial response (PR) or complete response (CR), CD63 was significantly decreased (p = 0.043), whereas perforin was significantly increased (p = 0.001). In the NAC of 16 patients with OC, CD63 of the response rate to chemotherapy tended to differ between the progressive disease (PD) and PR/CR groups (p = 0.056). A moderate inverse correlation was observed between CD63 and perforin levels (R = 0.638, R2 = 0.428, p = 0.008).
Thuật ngữ chủ đề	Obstetrics
Từ khóa tự do	Advanced stage; Ovarian cancer
Tác giả(bs) CN	Vũ Thúy Hà
Địa chỉ	100Kho Bài báo quốc tế(1): BQT00075
Tệp tin điện tử	https://pubmed.ncbi.nlm.nih.gov/39799740/
Tệp tin điện tử	https://lib.hpmu.edu.vn/kiposdata2/tapchi2026/anhbiatc/biabbqt_thumbimage.jpg

MARC

Hiển thị đầy đủ trường & trường con

Tag	Giá trị
000	00000nab#a2200000ui#4500
001	33998
002	13
004	F5721812-A87A-451E-9DBB-8BB9467AA951
005	202605151624
008	081223s2025 vm\| vie
009	1 0
039	[ ] \|y 20260515162412 \|z phuongntt
041	[ ] \|a Eng
084	[ ] \|a C20
100	[ ] \|a Đào Thị Hải Ly
245	[ ] \|a CD63 as a potential biomarker for patients with ovarian cancer
260	[ ] \|b ELSEVIER, \|c 2025
520	[ ] \|a In terms of stages, CD63 expression was significantly higher in patients with stage IV compared to those with stage I OC (p = 0.003). In terms of histological type, CD63 expression was significantly higher in high-grade serous carcinoma (HGSC) than in clear cell carcinoma (CCC) with OC (p = 0.009). Furthermore, CD63 levels were significantly higher in advanced-stage, HGSC than in patients with early-stage, non-HGSC and early-stage, HGSC OC (p = 0.045 and p = 0.002, respectively). In the Neoadjuvant chemotherapy (NAC) of 12 patients with OC assessed as having either a partial response (PR) or complete response (CR), CD63 was significantly decreased (p = 0.043), whereas perforin was significantly increased (p = 0.001). In the NAC of 16 patients with OC, CD63 of the response rate to chemotherapy tended to differ between the progressive disease (PD) and PR/CR groups (p = 0.056). A moderate inverse correlation was observed between CD63 and perforin levels (R = 0.638, R2 = 0.428, p = 0.008).
650	[ ] \|a Obstetrics
653	[ ] \|a Advanced stage
653	[ ] \|a Ovarian cancer
691	[ ] \|a CTĐT Bác sĩ nội trú Sản phụ khoa
700	[ ] \|a Vũ Thúy Hà
773	[ ] \|t Eur J Obstet Gynecol Reprod Biol
852	[ ] \|a 100 \|b Kho Bài báo quốc tế \|j (1): BQT00075
856	[ ] \|u https://pubmed.ncbi.nlm.nih.gov/39799740/
856	[1 ] \|u https://lib.hpmu.edu.vn/kiposdata2/tapchi2026/anhbiatc/biabbqt_thumbimage.jpg
890	[ ] \|a 1 \|b 0 \|c 0 \|d 0

Dòng	Mã vạch	Bản sao	Nơi lưu	Tình trạng	Cho phép yêu cầu
1	BQT00075	1	Kho Bài báo quốc tế
#1 BQT00075 Nơi lưu Kho Bài báo quốc tế Tình trạng

Bình luận